Aspirin superior to DAPT for bleeding in patients treated with TAVI - PACE-CME

Aspirin superior to DAPT for bleeding in patients treated with TAVI

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

No difference in outcomes after 5 years with anti-ischemic metabolic agent in patients after PCI
No difference in outcomes after 5 years with anti-ischemic metabolic agent in patients after PCI
ESC 2020
No difference in outcomes after 5 years with anti-ischemic metabolic agent in patients after PCI
- Prof. Freek Verheugt, MD
No clinical benefit from suspending ACEi/ARBs in hospitalized patients with COVID-19
No clinical benefit from suspending ACEi/ARBs in hospitalized patients with COVID-19
ESC 2020
No clinical benefit from suspending ACEi/ARBs in hospitalized patients with COVID-19
- Prof. Renato D. Lopes, MD, PhD
Incredible consistency between two SGLT2i trials in HFrEF
Incredible consistency between two SGLT2i trials in HFrEF
ESC 2020
Incredible consistency between two SGLT2i trials in HFrEF
- Milton Packer, MD
A step ahead in the management of HFmrEF and HFpEF
A step ahead in the management of HFmrEF and HFpEF
ESC 2020
A step ahead in the management of HFmrEF and HFpEF
- Prof. Burkert Pieske